Martire fallimento Perla triple negative breast cancer clinical features and patterns of recurrence Per favore, guarda batteri forno
Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network - The Breast
Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer | PLOS ONE
Different Pattern of Recurrence for Triple-negative Breast Cancer - CancerConnect
PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar
Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer | Scientific Reports
Triple-negative breast cancer molecular subtyping and treatment progress
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence | Scientific Reports
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer: Molecular Therapy - Nucleic Acids
Triple Negative Breast Cancer Pathophysiology | Oncology Nurses Quality Improvement Series
Locoregional recurrence of triple-negative breast cancer: effect of ty | BCTT
JCM | Free Full-Text | Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer | HTML
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics | PLOS ONE
Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: have we been bringing owls to Athens? - Annals of Oncology
Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer - The Breast
Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer - Journal of Geriatric Oncology
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients | British Journal of Cancer
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies - ESMO Open
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar
Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer | American Society of Clinical Oncology Educational Book
Risk of recurrence in different sites in triple-negative breast cancer... | Download Scientific Diagram
Cureus | Clinical Behavior of Triple Negative Breast Cancer in a Cohort of Latin American Women
Frontiers | Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial ...